170 related articles for article (PubMed ID: 666300)
1. In vitro activity of rifampin alone and in combination with nafcillin and Vancomycin against pathogenic strains of Staphylococcus aureus.
Tuazon CU; Lin MY; Sheagren JN
Antimicrob Agents Chemother; 1978 May; 13(5):759-61. PubMed ID: 666300
[TBL] [Abstract][Full Text] [Related]
2. Synergy between vancomycin and nafcillin against Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
Leonard SN
PLoS One; 2012; 7(7):e42103. PubMed ID: 22848719
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of clindamycin in combination with oxacillin, rifampin, or vancomycin against Staphylococcus aureus.
Ho JL; Klempner MS
Diagn Microbiol Infect Dis; 1986 Feb; 4(2):133-8. PubMed ID: 3956136
[TBL] [Abstract][Full Text] [Related]
4. Antagonism between nafcillin or oxacillin and rifampin against Staphylococcus aureus.
Watanakunakorn C; Tisone JC
Antimicrob Agents Chemother; 1982 Nov; 22(5):920-2. PubMed ID: 7181497
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of the bactericidal activity of ampicillin/sulbactam, piperacillin/tazobactam, imipenem or nafcillin alone and in combination with vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) in time-kill curves with infected fibrin clots.
Palmer SM; Rybak MJ
J Antimicrob Chemother; 1997 Apr; 39(4):515-8. PubMed ID: 9145825
[TBL] [Abstract][Full Text] [Related]
6. Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus.
Hackbarth CJ; Chambers HF; Sande MA
Antimicrob Agents Chemother; 1986 Apr; 29(4):611-3. PubMed ID: 3707110
[TBL] [Abstract][Full Text] [Related]
7. Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus.
Bayer AS; Morrison JO
Antimicrob Agents Chemother; 1984 Aug; 26(2):220-3. PubMed ID: 6567464
[TBL] [Abstract][Full Text] [Related]
8. Differences in ability of cell-wall antibiotics to suppress emergence of rifampicin resistance in Staphylococcus aureus.
Eng RH; Smith SM; Buccini FJ; Cherubin CE
J Antimicrob Chemother; 1985 Feb; 15(2):201-7. PubMed ID: 3845078
[TBL] [Abstract][Full Text] [Related]
9. Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.
LaPlante KL; Rybak MJ
Antimicrob Agents Chemother; 2004 Dec; 48(12):4665-72. PubMed ID: 15561842
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of cefmenoxime, cefotaxime, latamoxef, cefazolin, nafcillin and vancomycin against 53 endocarditis and bacteremic strains of Staphylococcus aureus.
Dhawan VK; Maier MK; Nayyar M; Chuah SK; Thadepalli H
Chemotherapy; 1984; 30(5):328-30. PubMed ID: 6092007
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci.
Tuazon CU; Miller H
Antimicrob Agents Chemother; 1984 Apr; 25(4):411-2. PubMed ID: 6233934
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the combination of daptomycin and nafcillin against vancomycin-intermediate Staphylococcus aureus.
Leonard SN; Rolek KM
J Antimicrob Chemother; 2013 Mar; 68(3):644-7. PubMed ID: 23152482
[TBL] [Abstract][Full Text] [Related]
13. Rifampin therapy of Staphylococcus epidermidis. Use in infections from indwelling artificial devices.
Archer GL; Tenenbaum MJ; Haywood HB
JAMA; 1978 Aug; 240(8):751-3. PubMed ID: 671704
[TBL] [Abstract][Full Text] [Related]
14. Bacteriological efficacy of nafcillin and vancomycin alone or combined with rifampicin or amikacin in experimental meningitis due to methicillin-susceptible or -resistant Staphylococcus aureus.
Sato K; Lin TY; Weintrub L; Olsen K; McCracken GH
Jpn J Antibiot; 1985 Aug; 38(8):2155-62. PubMed ID: 3852897
[TBL] [Abstract][Full Text] [Related]
15. Effects of vancomycin versus nafcillin in enhancing killing of methicillin-susceptible Staphylococcus aureus causing bacteremia by human cathelicidin LL-37.
Le J; Dam Q; Schweizer M; Thienphrapa W; Nizet V; Sakoulas G
Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1441-7. PubMed ID: 27234592
[TBL] [Abstract][Full Text] [Related]
16. Failure of time-kill synergy studies using subinhibitory antimicrobial concentrations to predict in vivo antagonism of cephalosporin-rifampin combinations against Staphylococcus aureus.
Brandt CM; Rouse MS; Tallan BM; Wilson WR; Steckelberg JM
Antimicrob Agents Chemother; 1994 Sep; 38(9):2191-3. PubMed ID: 7811044
[TBL] [Abstract][Full Text] [Related]
17. Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics.
Fox PM; Lampen RJ; Stumpf KS; Archer GL; Climo MW
Antimicrob Agents Chemother; 2006 Sep; 50(9):2951-6. PubMed ID: 16940087
[TBL] [Abstract][Full Text] [Related]
18. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin].
Kotulová D; Slobodníková L
Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovafloxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by time-kill curve methods.
Hershberger E; Aeschlimann JR; Moldovan T; Rybak MJ
Antimicrob Agents Chemother; 1999 Mar; 43(3):717-21. PubMed ID: 10049300
[TBL] [Abstract][Full Text] [Related]
20. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Smith JR; Yim J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
